NEPHRAEGIS THERAPEUTICS
Nephraegis Therapeutics is a biopharmaceutical company developing NPH-022 to prevent and treat Acute Kidney Injury (AKI).
NEPHRAEGIS THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Medical Therapeutics
Founded:
2018-01-01
Address:
Lake Forest, Illinois, United States
Country:
United States
Website Url:
http://www.nephraegis.com
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Organization Schema Typekit LocalBusiness Schema Squarespace
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Ceptaris Therapeutics
Ceptaris Therapeutics is a pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Current Advisors List
Current Employees Featured
Investors List
Xontogeny
Xontogeny investment in Seed Round - Nephraegis Therapeutics
Official Site Inspections
http://www.nephraegis.com
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 13.248.213.45
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
